Results 61 to 70 of about 461 (125)

Future Directions in the Medical Treatment of Obesity: A Narrative Review. [PDF]

Adv Ther
Bassatne A, Rizo I.
europepmc   +1 more source

Expanding the Treat-to-Target Toolbox for Obesity and Diabetes Care. [PDF]

N Engl J Med
Hales CM.
europepmc   +1 more source

Should Incretin Agonist-Based Brugs be Considered for First Line Antihypertensive Therapy? [PDF]

Curr Hypertens Rep
Kylies D, Dreher L, Wenzel UO.
europepmc   +1 more source

Do no harm: managing nausea and vomiting in GLP-1 based obesity therapies. [PDF]

Front Endocrinol (Lausanne)
Alhazmi A, le Roux CW.
europepmc   +1 more source

Bariatric Surgery in the Era of GLP1RA: A Narrative Review. [PDF]

Adv Ther
Muhundan M, Dash S.
europepmc   +1 more source

ESI Clinical Practice Guidelines for the Evaluation and Management of Obesity in India - An Update (2025). [PDF]

Indian J Endocrinol Metab
Madhu SV, Kapoor N, Das S, Raizada N, Kalra S.   +4 more
europepmc   +1 more source

Management of Obese Patients with Cardiovascular Disease with Emerging Weight-Lowering Drugs: A Narrative Review. [PDF]

Biomedicines
Ciarloni A, Salvio G, Bordoni M, Giacchetti G, Balercia G.   +4 more
europepmc   +1 more source

Optimal Medical Therapy Targeting Metabolic Status for Secondary Prevention in Patients Undergoing Percutaneous Coronary Intervention. [PDF]

J Clin Med
Forzano I, Narciso V, Canonico ME, Castiello DS, Florimonte D, Manzi L, Semplice F, Vallone DM, Cristiano S, Spinelli A, D'Alconzo D, Paolillo R, Giugliano G, Cesaro A, Gragnano F, Calabrò P, Esposito G, Gargiulo G.   +17 more
europepmc   +1 more source

Amylin: From Mode of Action to Future Clinical Potential in Diabetes and Obesity. [PDF]

Diabetes Ther
Volčanšek Š, Koceva A, Jensterle M, Janež A, Muzurović E.   +4 more
europepmc   +1 more source

Recent developments in GPCR signalling in appetite regulation. [PDF]

Biosci Rep
Brittain HR, Gorvin CM.
europepmc   +1 more source